Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Aspira Women's Health Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 47 | 45 | −2 |
| Shares | 9.73M | 8.87M | −853.7K (−8.8%) |
| Value | $3.24M | $3.25M | +$10.2K (+0.3%) |
New holders (6)
Institutions that held Aspira Women's Health Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dynamic Advisor Solutions LLC | 60,375 | $22.1K | 0.00% |
| FirstPurpose Wealth LLC | 27,907 | $10.2K | 0.01% |
| Wallace Advisory Group, LLC | 20,773 | $7.60K | 0.01% |
| Envestnet Asset Management Inc | 17,147 | $6.28K | 0.00% |
| LPL Financial LLC | 16,557 | $6.06K | 0.00% |
| Sawtooth Solutions, LLC | 12,500 | $4.58K | 0.00% |
Sold out (8)
Institutions that held Aspira Women's Health Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oracle Investment Management Inc | 728,100 | $242.2K |
| Sabby Management, LLC | 598,101 | $198.9K |
| Perkins Capital Management Inc | 200,000 | $67.0K |
| Castleview Partners, LLC | 19,750 | $6.57K |
| Citadel Advisors LLC | 17,036 | $5.67K |
| Warberg Asset Management LLC | 15,000 | $5.10K |
| Jane Street Group, LLC | 13,027 | $4.33K |
| Rockefeller Capital Management L.P. | 1,000 | $0 |